Sepsis & infection

Performance and impact of rapid multiplex PCR on diagnosis and treatment of ventilated hospital-acquired pneumonia in patients with extended-spectrum β-lactamase-producing Enterobacterales rectal carriage

Ann Intensive CarePublished Prospective cohort study

Authors' conclusion

mPCR blaCTX-M showed an excellent diagnostic value to rule out the diagnosis of ESBL-E related pneumonia in ESBL-E carriers with suspected VAP/vHAP. In addition, in patients with confirmed VAP/vHAP, a mPCR-based antibiotic therapy was associated with an increased prescription of adequate empirical antibiotic therapy.

Study context

Population
ICU patients with ESBL-E rectal carriage with suspected or confirmed ventilator-associated pneumonia (VAP)/ventilated hospital-acquired pneumonia (vHAP)168 (57%) mechanically ventilated
Participants
294 patients
Exposure
mPCR (BioFire FilmArray Pneumonia plus Panel) vs conventional culture; mPCR vs no mPCR for initial antibiotic therapy
  • mPCRn = 22
  • Without mPCRn = 73reference
Outcome
Concordance between mPCR and conventional culture on respiratory samples for suspected VAP/vHAP
Methodological detailsmonocentric, March 2020 to August 2022
  • Monocentric
  • March 2020 to August 2022

Main finding

As reported in the abstract

Concordance of mPCR blaCTX-M with conventional culture for ESBL-E (suspected VAP/vHAP)
Suspected VAP/vHAP episodes evaluated
41
blaCTX-M detected
15/41 (37%)
Confirmed ESBL-E-induced pneumonia among blaCTX-M-positive episodes
9/15 (60%)
Culture never detected ESBL-E in blaCTX-M-negative episodes
n = 26
Culture and blaCTX-M concordant
35/41 (85%)

Observational data: associations, not effects.

Secondary outcomes

OutcomeaOR (95% CI)P value
Adequate empirical antibiotic therapy in confirmed VAP/vHAP (95 episodes)mPCR vs without mPCR · multivariable logistic regression7.5 (2.1–35.9)P = 0.004
Adequate empirical antibiotic therapy in confirmed VAP/vHAP (95 episodes)mPCR vs without mPCR · propensity-weighting5.9 (1.6–22.1)P = 0.008
Adequate empirical antibiotic therapy in confirmed VAP/vHAP (95 episodes)mPCR vs without mPCR · matching-cohort5.8 (1.5–22.1)P = 0.01
Adequate empirical antibiotic therapy in confirmed VAP/vHAP (95 episodes) — ESBL-E-induced episodes
47 (49%)
Adequate empirical antibiotic therapy in confirmed VAP/vHAP (95 episodes) — Carbapenem-resistant bacteria-induced episodes
24 (25%)

Original publication

Performance and impact of rapid multiplex PCR on diagnosis and treatment of ventilated hospital-acquired pneumonia in patients with extended-spectrum β-lactamase-producing Enterobacterales rectal carriage. Ann Intensive Care. Published 29 July 2024. doi:10.1186/s13613-024-01348-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.